CompoAtlas

DYNA ALFALFA PLUS GUARANA LIQUID

DYNA ALFALFA PLUS GUARANA LIQUID : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Registration number
MAL25116133T
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
Diamond Interest Sdn Bhd
Manufacturer
DYNAPHARM HERBAL (M) SDN. BHD.
Registration period starting
2025-11-03
Published validity end
2030-11-03

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Medicago sativaMedicago sativa[25 mg,15 ml]Not identified
Paullinia cupanaPaullinia cupana[30 mg,15 ml]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Original register data

View published fields and their variants
Active ingredients
Medicago sativa[25 mg,15 ml],Paullinia cupana[30 mg,15 ml]
Valid until
2030-11-03
Registration date
2025-11-03
Published description
NATURAL PRODUCT
Licence holder
Diamond Interest Sdn Bhd
Producer
DYNAPHARM HERBAL (M) SDN. BHD.
Published name
DYNA ALFALFA PLUS GUARANA LIQUID
Published reference
2025063019138T
Registration number
MAL25116133T
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL25116133T

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Medicago sativa
    Read the warning, when it applies and the studies cited

    ALFALFA - MEDICAGO SATIVA

    Route of administration: Oral

    Cautions and warnings

    Applies to products providing more than 900 mg of Alfalfa dried herb top/leaf, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners, birth control medication or hormone therapy (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Condition of application: All products.

    Do not use if you are pregnant or breastfeeding (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Applies to products providing more than 900 mg of Alfalfa dried herb top/leaf, per day.

    Do not use if you have a history of systemic lupus erythematosus (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 November 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line